Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin in Frail Elderly
NCT01605435Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-blind trial of human ghrelin in frailty syndrome, sponsored by University of Pennsylvania. Primary endpoint: Treatment Emergent Adverse Events at 30 days. Started May 2012; status: completed.
02
Drugs
human ghrelin
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT01605435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605435.